CHFR Methylation Status Esophageal Cancer Study

NCT01372202 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

31

Enrollment

OTHER

Sponsor class

Stopped Study stopped due to early stopping rule

Conditions

Esophageal Cancer

Interventions

DRUG: Paclitaxel
DRUG: Cisplatin
DRUG: Oxaliplatin
DRUG: 5-Fluorouracil
RADIATION: Radiotherapy
PROCEDURE: Esophagectomy

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Collaborators

[object Object]